Terran Biosciences announces licensing deal with Sanofi for tw...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
NEW YORK, April 21, 2022 /PRNewswire-AsiaNet/ -- -- Terran to advance the development of two of Sanofi's Phase 3 CNStherapeutics-- Transaction includes worldwide exclusive rights for development and commercialization in all fields of useTerran Biosciences, Inc. ...
Authors: LATEST ASIANET NEWS RELEASES